Population
Elderly patients (≥75 years of age) with acute myocardial infarction
Design
Review
Authors
Loading...
May support standard AMI therapies in selected elderly patients; leaves open confirmation from dedicated randomized trials.
This review emphasizes that despite a lack of dedicated randomized trial data, elderly patients with acute myocardial infarction should generally receive standard evidence-based therapies including reperfusion.
Michael W. Rich (2001) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: